To do or not to do: Angiotensin converting enzyme inhibitors/angiotensin receptor blocker in COVID-19 elderly patients

Authors

DOI:

https://doi.org/10.17179/excli2021-3821

Keywords:

COVID 19, Angiotensin converting enzyme inhibitors, Angiotensin Receptor Blocker, elderly patients, hypertension

Author Biographies

Naga Venkata Rama Krishna Vura, Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio

Department of Internal Medicine

Rashi Sandooja, Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio

Department of Internal Medicine

Published

2021-07-06

How to Cite

Vura, N. V. R. K. ., Sandooja, R. ., & Firoz, A. (2021). To do or not to do: Angiotensin converting enzyme inhibitors/angiotensin receptor blocker in COVID-19 elderly patients. EXCLI Journal, 20, 1145–1151. https://doi.org/10.17179/excli2021-3821

Issue

Section

Letters to the editor

Most read articles by the same author(s)